Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

If lifestyle changes and strategies don’t work, or if your case is severe, your doctor may prescribe medication to help you manage your hot flashes. Hot flashes can also be a side effect of ...

A drug under development could provide a much needed option for women seeking relief from hot flashes and other menopausal symptoms, new research shows. The drug, elinzanetant, cut the frequency ...

Overconsumption of caffeine, spicy foods, and heart and blood pressure medications have also been shown to trigger hot flashes in some people. When triggered by such medical conditions or ...

A new era of menopause treatment looks to be on the horizon. This week, drugmaker Bayer published the results of two successful Phase III trials testing its experimental drug elinzanetant as a ...

A new treatment for hot flashes brought relief and a better night’s rest for women experiencing these disruptive symptoms during menopause. Two phase 3 clinical trials compared the drug ...

The investigational drug elinzanetant reduces hot flashes while improving women's sleep and quality of life, new research finds. The investigational drug elinzanetant significantly reduces the ...

The traditional treatment for vasomotor symptoms related to menopause -- like hot flashes -- has been hormone replacement therapy (HRT). HRT consists of estrogen given as a pill, patch ...

The investigational drug elinzanetant significantly reduces the frequency and severity of hot flashes associated with menopause while improving women's quality of life, according to new UVA Health ...